Regen BioPharma Inc (RGBP)

[kfox]

That's the big question. Lander's bonus is tied to transacting a partnership with a BP whose sales exceed 250 million. He alluded to discussions with those kind of firms in his January letter. My assumption is that a partnership funds Hema and other INDs. Another source would come from grants accessible if they are successful with their ODD application. That would be partial funding but highly significant if achieved. Lander's alluded to their recent FF raise as funding an unspecified study that I'm assuming is their small molecule effort.